K2 the next D3
Our new Material:
- K2VITAL® ExperienceCard concept products, available for license‑free launch.
- 5th Edition Formulation LookBook
- and many more
Free of charge Label Claim Testing
Shelf stability is vital to successful K2 products –ensuring quality to customers and brands.
Do your K2 MK-7 products meet label claim?
Are they pure, all-trans bioactive MK-7?
The Kappa portfolio of premium ingredients represents a team of Superheroes for the bone and heart dietary supplements health categories.
Kappa deeply believes in the promise of vitamin K2 MK-7 and has a mission to improve health and well-being globally. Kappa developed the K2 Academy as a learning center on all facets of vitamin K2, from history to health, manufacturing to final formulation. The Academy includes a range of tools in a variety of formats educate new distributors, customers and the public on the promise of K2VITAL®.
The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process. The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential.